CYP1A1 and inflammatory bowel disease: This is not to say that induction of Cyp1a1 should be disregarded; indeed, a modest induction of Cyp1a1 in gene expression profiling sparked the discovery that the anti-inflammatory drug mesalamine ameliorates inflammatory bowel disease by interacting with the AHR10.